Bioprocess Control is a market leader in the area of low gas flow analytical instruments for biotechnology related and other applications. The company was founded in 2006 and today brings to market more than 17 years of industry leading research and product development in the area of smart analytical instruments. Bioprocess Control currently has customers in over 60 countries and regions around the world with more added every year.
Bioprocess Control's flagship product the Automatic Methane Potential Test System or AMPTS is the preferred analytical instrument for conducting various anaerobic batch fermentation tests including biochemical methane potential (BMP) and specific methanogenic activity (SMA) tests. The instrument is widely used by academic and commercial actors who have benefited from significant improvements in data quality and labour savings. Bioprocess Control also offers a portfolio of exciting smart instruments for low gas flow measurement, in-vitro digestibility analysis of animal feed, biochemcial oxygen demand (BOD), specific Anammox activity (SAA) analysis and more.
To bring to market innovative low gas flow analytical instruments that allow for more efficient and higher quality research and analysis, leading to significant reductions in time and labour.
To become a global leader in low gas flow analytical instruments for a broad range of research and commercial applications across multiple industries.
We invest in innovation and the development of smart instruments, ensure the highest product quality throughout our portfolio, and focus on being service minded and always meeting the needs of our customers.